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The association between impairment in mitochondrial muscle fat oxidative capacity (OXFA) and
occurrence of insulin resistance was examined in 14 healthy trained men (age, 24 ± 4 yr) submitted
to 4 weeks of training cessation. Training stop induced a signiﬁcant decrease in mRNA levels of pro-
teins involved in muscle fat metabolism, particularly PPARa (58%, P < 0.01) and PGC-1a (30%,
P < 0.05), a 21% reduction in OXFA (P < 0.01), and reduced fat oxidation during moderately intense
exercise (P < 0.05). In contrast, there was no signiﬁcant alteration in insulin sensitivity. In conclu-
sion, decline in OXFA is a rapid metabolic event following training cessation. It is involved in the reg-
ulation of whole body fat balance but not in the deterioration of insulin sensitivity.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction studies have demonstrated that high-fat diet induced-insulin resis-Insulin resistance in skeletal muscle precedes and predicts the
development of type 2 diabetes [1,2]. Decreased muscle mitochon-
drial oxidative function [3] and fat oxidative capacity [4,5] has
been considered as a risk factor for insulin resistance. Indeed, de-
creased fat oxidation and excess fat storage can promote the intra-
myocellular accumulation of fatty acid metabolites (e.g.
diacylglycerols and ceramides) known to impede the insulin signal
transduction pathway [6,7]. This assumption has been supported
by several cross-sectional studies [3,4,8]. Furthermore, we previ-
ously reported that 8 weeks of progressive endurance training im-
proved insulin sensitivity in parallel with muscle fat oxidative
capacity (OXFA) in healthy elderly people [8]. In contrast, recentchemical Societies. Published by E
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.tance can be dissociated from muscle mitochondrial function [9].
The present study aimed to tackle these controversies by examin-
ing whether any intervention known to induce a decline in OXFA is
or is not associated with impaired insulin sensitivity. For this pur-
pose, we considered short-term training cessation as a pertinent
model for investigating the early mechanisms responsible for de-
creased OXFA [10,11] and its association with changes in insulin
sensitivity. We studied healthy adults to determine the conse-
quences of 4 weeks of training cessation on: (1) muscle fat oxida-
tive capacity (both at skeletal muscle mitochondrial level (OXFA)
and whole body level), (2) mRNA expression of genes encoding ma-
jor enzymes and proteins controlling the muscle fat oxidative
pathway, and (3) the association between alterations in muscle
fat metabolism and changes in insulin sensitivity.
2. Materials and methods
2.1. Subjects
The intervention study involved 14 healthy men (23.7 ± 3.9 yr)
who regularly practiced exercise >4 h/week (i.e. cycling and/or
running). A control group was formed with six sedentary healthylsevier B.V. All rights reserved.
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non-smokers, not suffering from any diagnosed disease, and under
no medication known to inﬂuence energy and lipid metabolism.
Subjects were included in the study following a maximal aerobic
power test performed to conﬁrm the declared volume of sport
exercise. Maximal oxygen consumption (VO2max) averaged
53.0 ± 3.5 and 38.5 ± 3.2 ml/min/kg/body weight for the trained
subjects and the sedentary individuals, respectively (P < 0.0001).
The nature and potential risks of the study were fully explained,
and written informed consent was obtained from each participant.
The experimental protocol was approved by the Clermont–Ferrand
ethical committee (No. AU533) and was performed according to
the principles expressed in the Declaration of Helsinki, as revised
in 2000.
2.2. General study design
2.2.1. Intervention study
The inclusion trial consisted of an activity questionnaire, a med-
ical examination and a maximal aerobic power test. The measure-
ment period started the ﬁrst week with a moderate aerobic power
test and heart rate recordings during 7 days in free-living condi-
tions. The training cessation protocol lasted for 4 weeks (from
week 2 to week 6). The subjects stopped sport exercise 2 days be-
fore initial metabolic measurements that included basal indirect
calorimetric measurement, muscle biopsy, 3-h euglycemic–hype-
rinsulinemic clamp, and body composition determination. From
two days before and throughout the metabolic measurements,
the volunteers were placed on a controlled diet (35%, 50% and
15% of energy in the form of lipids, carbohydrates and proteins,
respectively) [12]. Heart rate was re-recorded over 7 days in
free-living conditions at the end of the training cessation period.
Thereafter, the ﬁnal metabolic measurements repeating the initial
measurements were performed while diet was similarly con-
trolled. Finally, 4 days after the ﬁnal muscle biopsy, the volunteers
underwent moderate and maximal aerobic power tests.
2.2.2. Control group
After the inclusion trial, the subjects were placed on a con-
trolled diet and the metabolic measurements included a muscle
biopsy, a 3-h euglycemic–hyperinsulinemic clamp, and body com-
position measurement.
2.3. Physical activity characterization
2.3.1. Maximal aerobic power test
The tests were all performed on the same cycloergometer
(Ergomeca, Monark, Sweden) under cardiovascular supervision
by a cardiologist, as described in [12].
2.3.2. Heart rate (HR) recording
HR was recorded minute-by-minute using telemetry (Polar pro-
trainerTM, Polar Electro Oy, Finland) during seven consecutive days.
The time spent per day at speciﬁc activity intensities (<40%, 40–
60% and >60% of VO2max) was calculated using the individual rela-
tionship between HR and %VO2max established during the maximal
aerobic power test [12].
2.4. Body composition assessment
A transverse total body scan was performed using DEXA (Hologic
QDR 4500 X-ray bone densimeter, Hologic, Waltham, MA) for
determination of total and regional (arms, legs and trunk) body
composition [13]. Appendicular muscle mass was calculated as
the sum of the fat-free mass of both arms and legs.2.5. Whole body substrate oxidation
2.5.1. Basal indirect calorimetric measurements
After an overnight fast, basal non-protein respiratory ex-
change ratio (RER) and energy expenditure (resting EE) were
measured using open-circuit indirect calorimetry (Deltatrac,
Datex, Geneva).
2.5.2. Moderate aerobic power test
The test was performed at least 3 h after the last meal and con-
sisted of ﬁve sessions (at 25, 30, 40, 50 and 60%VO2max) of 6 min
per session on a cycloergometer [14]. RER was determined at each
session taking into account the last 2-min values using indirect cal-
orimetry (VIASYS, Oxycon Pro, JAEGER, Germany).
2.6. Daily energy expenditure (daily EE)
Daily EE was calculated from the 7 day-HR recordings in free-
living conditions. The individual relationship between HR and EE
from basal indirect calorimetry and maximal aerobic power test
measurements was used [12].
2.7. Blood sampling
After an overnight fast, blood samples were collected and plas-
ma was kept at 80 C until further analysis. Plasma concentra-
tions of glucose, insulin, triglycerides (TG) and non-esteriﬁed
fatty acids (NEFA) were determined using commercial kits, as de-
scribed in [8,13].
2.8. Insulin sensitivity
Insulin sensitivity was assessed after an overnight fast using a
3-h euglycemic–hyperinsulinemic clamp [15]. The steady-state
period was reached during the last 60 min. The index of insulin
sensitivity, i.e. M/(G  DI) ratio, was calculated according to Katz
et al. [15].
2.9. Muscle biopsy and assays
2.9.1. Muscle biopsy
After an overnight fast and before the insulin clamp was per-
formed, percutaneous needle biopsies (180–250 mg) were ob-
tained from the vastus lateralis muscle under local anesthetic
(5 ml lidocaine 2%). Muscle biopsies were dissected free of blood,
connective tissue and fat.
2.9.2. Muscle fat oxidative capacity
[1-14C]palmitate oxidation by fresh muscle homogenate was
performed using the method described in [13].
2.9.3. Muscle enzyme activities
Citrate synthase (CS), complex I, complex II, complex III, cyto-
chrome c oxidase (COX) and beta-hydroxyacyl CoA dehydrogenase
(HAD) activities were assayed spectrophotometrically on the above
muscle homogenates (after storage at 80 C) as described by
Rustin et al. [16] and Morio et al. [13].
2.9.4. Preparation of total RNA
Total RNA was prepared from frozen muscle samples accord-
ing to a procedure based on the method of Chomczynski and
Sacchi [17]. Average yields of total RNA were 26 ± 2 lg/100 mg
of muscle (wet weight) and were not signiﬁcantly different be-
fore and after training cessation. Total RNA solutions were stored
at 80 C.
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First-strand cDNAs were ﬁrst synthesised from 500 ng of total
RNA in the presence of 100 units of Superscript II (Invitrogen, Erag-
ny, France) using both random hexamers and oligo (dT) primers
(Promega, Charbonnières, France) [18]. The real-time PCR was per-
formed in a ﬁnal volume of 20 ll containing 5 ll of a 60-fold dilu-
tion of the RT reaction medium, 15 ll of reaction buffer from the
FastStart DNA Master SYBR Green kit (Roche Diagnostics) and
10.5 pmol of the speciﬁc forward and reverse primers (Eurobio,
Les Ulis, France). Primers were selected in order to amplify small
fragments (80–200 bp) and to hybridise in different exons of the
target sequences. A list of primers and real-time PCR conditions
for each mRNA assay is available upon request (www.vidal@laen-
nec.univ-lyon1.fr). For quantiﬁcation, a standard curve was sys-
tematically generated with six different amounts (150–
30 000 molecules/tube) of puriﬁed target cDNA cloned in the
pGEM plasmid (Promega). Each assay was performed in duplicate
and validation of the real-time PCR runs was assessed by evaluat-
ing the melting temperature of the products, and by the slope and
error obtained with the standard curve. The analyses were per-
formed using Light-Cycler software (Roche Diagnostics). The re-
sults were presented as absolute concentrations, in amol/lg of
total RNA. Cyclophilin mRNA levels were measured as internal
standard. Similar concentration of cyclophilin mRNA was found
in skeletal muscle before and after 4 weeks of detraining
(10.1 ± 2.4 and 11.2 ± 5.9 amol/lg total RNA, respectively,
P = 0.58). mRNAs corresponding to the genes of interest were
expressed relative to cyclophilin mRNA concentration. Thereafter,
results were presented as relative change between pre- and post-
training values (%).2.10. Statistical analysis
Results are reported as means ± S.D. A non-parametric Mann–
Whitney unpaired U-test was used to compare trained subjects
to the control group. Training cessation effects were assessed using
non-parametric Wilcoxon signed-rank (paired) test. Correlation
coefﬁcients are non-parametric Spearman’s rank correlations
(noted q). Results were considered statistically signiﬁcant at the
5% level. Statistical analysis was performed using Statview 5.0 soft-
ware (SAS Institute Inc., Cary, NC).3. Results
3.1. Physical characteristics of the subjects
Body composition was not signiﬁcantly different between con-
trol subjects and trained individuals (Table 1). In the intervention
study, body weight, body mass index (BMI) and muscle mass were
not signiﬁcantly altered by training cessation. Yet fat mass was sig-
niﬁcantly increased by 5.1% (P < 0.05) and fat-free mass showed a
slight but consistent and signiﬁcant 1.0% decrease (P < 0.05) after
training cessation.3.2. Experimental protocol compliance
As expected, the VO2max of trainedmen before training cessation
was 37.7% higher compared to sedentary subjects (Table 2). All
subjects from the intervention study complied with the 4 weeks of
training cessation. VO2max after training cessation decreased signif-
icantlyby8.3% (P < 0.01), butwas still 25.7%higher compared to sed-
entary subjects (P < 0.05, Table 2). Daily EE of trained men was not
signiﬁcantly altered after training cessation (Table 2), but time spent
per day at activity intensities between 40–60% and >60%VO2maxwas signiﬁcantly decreased by 60% and 94%, respectively (P < 0.05,
Table 3).
3.3. Muscle metabolic activity
3.3.1. Muscle fat oxidative capacity and mitochondrial enzyme
activities
OXFA (i.e. total oxidation rate of palmitate; Table 4) was 59%
higher in trained men before training cessation compared to sed-
entary subjects (P < 0.05). After training cessation, OXFA was signif-
icantly reduced by 21.4% (P < 0.01) to a level not signiﬁcantly
different from the sedentary subjects.
Training cessation induced a signiﬁcant reduction in the maxi-
mal activity of CS, HAD, complex II and complex III whereas the
maximal activity of complex I and COX was not signiﬁcantly al-
tered (Table 4). The relative changes of OXFA (i.e. post- vs. pre-
training values) were positively correlated with relative changes
in HAD (q = 0.80, P < 0.01), CS (q = 0.79, P < 0.01) and complex II
(q = 0.78, P < 0.01, Fig. 1). Similar results were obtained when
absolute changes were taken into account.
3.3.2. Muscle gene expression
The post- vs. pre-training relative changes in the expression of
nine transcripts in muscle are presented in Table 5. The mRNA
expression levels of proteins involved in long-chain fatty acid oxi-
dative metabolism (FABP3, FACL, CPT1, CPT2, and UCP3) were sig-
niﬁcantly decreased by 35% and more after 4 weeks of training
cessation (P < 0.05). By contrast, changes in mRNA expression lev-
els of FAT/CD36 were not signiﬁcant. Finally after training cessa-
tion, mRNA expression levels of PGC1a and PPARa were
signiﬁcantly decreased by 30% (P < 0.05) and 58% (P < 0.01),
respectively (Fig. 2), whereas mRNA expression of PPARb/d re-
mained unaffected.
3.4. Respiratory exchange ratio at rest and during exercise
At rest and in post-absorptive state, non-protein RER was not
altered after training cessation (Table 2) whereas RER during exer-
cise at similar relative intensities was signiﬁcantly increased by 5%
(P < 0.05) (Fig. 3).
3.5. Insulin sensitivity
Insulin sensitivity was signiﬁcantly higher in trained subjects
before and after training cessation compared to sedentary men
(P < 0.05). It was not signiﬁcantly altered by 4 weeks of training
cessation (Table 2).
3.6. Fasting plasma substrate and insulin concentrations
There were no signiﬁcance differences in fasting glucose and
insulin concentrations between trained and sedentary men before
and after training cessation (Table 2). After training cessation com-
pared to before, fasting plasma glucose and total triglyceride con-
centrations remained stable, whereas plasma NEFA concentrations
decreased by 23.5% (P < 0.05, Table 2).4. Discussion
The main purpose of our study was to determine whether de-
cline in muscle mitochondrial oxidative function would be a driv-
ing factor toward insulin resistance. It was important to establish
beforehand that the subjects complied with the training cessation
instructions. Heart rate recordings showed that the volunteers
Table 2
Metabolic characteristics of sedentary men (control group; n = 6) and young trained men (n = 14) before and after 4 weeks of training cessation.
Control group Pre-training cessation Training cessation period Difference (absolute value) Training cessation effect
VO2max (ml/min/kg/BW) 38.5 ± 3.2*
,** 53.2 ± 3.8 48.4 ± 3.2 4.67 ± 4.60 P < 0.01
Mean daily EE (MJ/day)  15.12 ± 4.08 13.32 ± 3.29 1.81 ± 3.06 NS
Fasting conditions
Resting EE (MJ/day)  7.81 ± 0.84 7.51 ± 0.75 0.30 ± 0.46 P < 0.05
RER  0.852 ± 0.041 0.857 ± 0.033 0.005 ± 0.040 NS
Plasma glucose (mmol/l) 4.82 ± 0.26 4.39 ± 0.53 4.56 ± 0.39 0.17 ± 0.57 NS
Plasma NEFA (lmol/l)  622 ± 200 440 ± 164 182 ± 225 P < 0.05
Plasma triglycerides (g/l)  0.83 ± 0.27 0.86 ± 0.28 0.03 ± 0.28 NS
Plasma Insulin (lIU/ml) 10.6 ± 5.0 10.5 ± 2.3 11.2 ± 2.4 0.7 ± 2 .1 NS
Insulin clamp
Plasma insulin (lIU/ml) 62.3 ± 5.8 65.9 ± 7.0 70.8 ± 11.7 5.1 ± 11.5 NS
M value (mg/kg/min) 3.65 ± 1.46*
,** 6.53 ± 1.81 5.94 ± 1.70 0.59 ± 1.49 NS
M/(G  DI) 7.9 ± 3.5*,** 13.1 ± 3.0 12.1 ± 4.8 1.0 ± 3.6 NS
Results are expressed as means ± S.D. VO2max, maximal oxygen uptake. EE, energy expenditure. RER, respiratory exchange ratio. NEFA, non-esteriﬁed fatty acids. M value,
glucose infusion at plateau.M/(G  DI), insulin sensitivity assessed using the index of Katz et al. [15] and expressed in 104 dL/min kg/(lIU/ml). Comparison between control
subjects and trained individuals.
* Signiﬁcantly different from pre-training cessation value at P < 0.0001.
** Signiﬁcantly different from post-training cessation value at P < 0.05.
Table 4
Muscle fat oxidative capacity and mitochondrial oxidative enzyme activity before and after 4 weeks of training cessation (n = 14), comparison with sedentary controls (n = 6).
Control group Pre-training cessation Post-training cessation Difference (absolute value) Training cessation effect
OXAG 26.7 ± 7.6* 43.5 ± 17.4 32.5 ± 9.4 11.0 ± 11.8 P < 0.01
HAD – 6.6 ± 1.7 5.5 ± 1.8 1.1 ± 1.5 P < 0.05
CS 24.9 ± 7.1*,** 37.4 ± 6.9 32.5 ± 6.5 4.7 ± 5.6 P < 0.05
Complex I – 7.6 ± 1.5 7.0 ± 1.3 0.6 ± 1.7 NS
Complex II – 5.5 ± 1.8 4.5 ± 1.4 1.1 ± 1.0 P < 0.01
Complex III – 0.41 ± 0.22 0.32 ± 0.18 0.08 ± 0.11 P < 0.05
COX 10.9 ± 1.4*,** 17.3 ± 5.0 18.1 ± 4.4 0.8 ± 4.2 NS
Results are expressed as means ± S.D. OXAG, muscle fat oxidative capacity expressed in nmol palmitate/min/g/wet tissue. Enzymatic activities of beta-hydroxyacyl CoA
dehydrogenase (HAD), citrate synthase (CS), complex I, complex II, complex III and cytochrome c oxidase (COX) are expressed in lmol/min/g wet tissue. Comparison between
control subjects and trained individuals.
* Signiﬁcantly different from pre-training cessation value at P < 0.05.
** Signiﬁcantly different from post-training cessation value at P < 0.05.
Table 1
Physical characteristics of sedentary men (control group; n = 6) and young trained men (n = 14) before and after 4 weeks of training cessation.
Control group Pre-training cessation Post-training cessation Difference (absolute value) Training cessation effect
Age (yr) 23.8 ± 2.4 23.7 ± 3.9
Height (cm) 177.6 ± 6.4 179.8 ± 8.0
Body weight (kg) 70.3 ± 9.8 72.2 ± 8.2 72.1 ± 7.9 0.06 ± 0.97 NS
BMI (kg m2) 22.2 ± 2.3 22.28 ± 1.44 22.26 ± 1.40 0.01 ± 0.28 NS
Fat mass (kg) 11.1 ± 2.8 9.7 ± 2.1 10.2 ± 2.3 0.50 ± 0.54 P < 0.01
Fat mass (%) 15.7 ± 2.5 13.4 ± 2.8 14.1 ± 3.0 0.71 ± 0.63 P < 0.01
Truncal fat mass (kg) 4.2 ± 1.1 3.5 ± 0.9 3.8 ± 1.0 0.27 ± 0.32 P < 0.05
Fat free mass (kg) 59.2 ± 8.3 62.7 ± 7.4 62.1 ± 7.5 0.63 ± 0.59 P < 0.01
Appendicular muscle mass (kg) 31.3 ± 2.5 30.3 ± 3.9 29.9 ± 4.0 0.44 ± 0.85 P = 0.064
Results are expressed as means ± S.D. BMI, body mass index. Comparison between control subjects and trained individuals.
Table 3
Compliance of the young trained men to the training cessation protocol (n = 14).
Pre-training cessation Training cessation period Difference (absolute value) Training cessation effect
Time spent at %VO2max < 40 (h/day) 23.44 ± 0.32 23.85 ± 0.17 0.41 ± 0.31 P < 0.05
Time spent at %VO2max = 40–60 (min/day) 25.4 ± 15.6 10.0 ± 12.9 15.4 ± 12.0 P < 0.05
Time spent at %VO2max > 60 (min/day) 10.8 ± 8.9 0.4 ± 0.6 10.8 ± 9.3 P < 0.05
Results are expressed as means ± S.D. VO2max, maximal oxygen uptake. Time spent at speciﬁc intensities of VO2max during the alert period were calculated using one week of
heart rate recordings before and during the training cessation period, and individual relationships between heart rate and %VO2max set up during rest and effort.
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Table 5
Post- vs. pre-training relative changes in mRNA levels of genes coding proteins
involved in muscle fatty acid metabolism (n = 9).
Post- vs. pre-training(%) Training cessation effect
Proteins involved in LCFA uptake, transport and activation
FAT/CD36 16.6 ± 41.1 NS
FABP3 34.8 ± 31.6 P < 0.05
FACL 38.0 ± 26.9 P < 0.05
CPT1 44.8 ± 30.1 P < 0.05
CPT2 48.3 ± 32.9 P < 0.05
UCP3 36.5 ± 30.0 P < 0.05
Proteins involved in the transcriptional regulation of genes of FA metabolism
PGC1a 30.5 ± 25.4 P < 0.05
PPARa 58.4 ± 20.1 P < 0.01
PPARb/d 20.3 ± 49.0 NS
Results are expressed as means ± S.D. LCFA, long-chain fatty acids; FA, fatty acids;
FAT/CD36, fatty acid translocase (UniGene Cluster number: Hs.75613); FABP3, fatty
acid binding proteins (Hs.49881); FACL, fatty-acid-CoA ligase (due to high sequence
similarity, the RT-PCR assay did not discriminate between FACL1 (Hs.406678) and
FACL2 (Hs.154890) mRNAs and they were thus quantiﬁed together); CPT1, palmi-
toyl-CoA transferase 1 (muscle form, Hs.29331); CPT2, palmitoyl-CoA transferase 2
(Hs.274336); UCP3, uncoupling protein 3 (Hs.101337); PGC1a, PPARa coactivator-
1a (Hs.198468); PPARa, peroxysome proliferator-activated receptor a (Hs.998);
PPARb, peroxysome proliferator-activated receptor b (Hs.106415). Results are
expressed post-training value relative to cyclophilin mRNA concentration divided
by pre-training value relative to cyclophilin mRNA concentration (%).
Relative changes in muscle mitochondrial complex II maximal activity (%)
ρ=0.78
P<0.01
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Fig. 1. Correlation between relative changes of muscle fat oxidative capacity and
mitochondrial complex II maximal activity, before and after 4 weeks of training
cessation (n = 14).
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intensity activity. Additional evidence was brought by the signiﬁ-
cant reduction in VO2max.
OXFA declined by 21% after 4 weeks of training cessation, in
association with decreased expression of two enzymes dedicated
to fatty acid transport within the organelle (CPT1 and CPT2) and
a reduced maximal activity of CS, complex II and complex III. These
results are in agreement with previous research reporting a 20–
45% decline in CS, succinate dehydrogenase and also HAD activities
after short-term training cessation (<4 weeks) in athletes [11]. It is
interesting to note that not all mitochondrial oxidative enzymes
were similarly affected by training cessation, since complex I and
COX activities were not signiﬁcantly altered. Changes in complex
II activity, as well as those of HAD, were highly correlated to the
decline in OXFA. HAD is a key enzyme of the b-oxidation pathway
while complex II is involved in the oxidation of FADH2, which is de-
rived principally from b-oxidation. This therefore suggests that
impairment in the muscle fat oxidative pathway is a rapid meta-
bolic event following physical training cessation. This is supportedat the whole-body level by the shift in RER during physical exercise
of moderate intensities, which evidences a decreased reliance on
fat oxidation during near-maximal stimulation of muscle oxidative
metabolism.
There is a growing body of evidence that muscle fatty acid
uptake and utilization are ﬁnely tuned mechanisms, most likely
in order to avoid any intracellular accumulation [19]. Decreased
expression of PPARa (58%) is likely involved in the speciﬁc
alteration of the muscle fat oxidative pathway, characterized in
particular by down-regulation of genes coding for key proteins
(FABP3, FACL, and UCP3) and enzymes (CPT1 and CPT2) involved
in muscle fat metabolism. This decrease is in agreement with stud-
ies showing that, conversely, endurance training doubles PPARa
gene expression [20,21]. Furthermore, fasting plasma NEFA con-
centrations were unexpectedly reduced by 23% after training ces-
sation. This might be related to the fact that subjects were
gaining fat: an increased fat storage activity associated with de-
creased lipolytic activity might temporally deplete the plasma
NEFA pool. However, this observation has not been reported in
the literature, and it might be only a transient adaptation. Given
that muscle fatty acid uptake has been correlated to plasma fatty
acid concentration [22], the decreased expression of PPARa may
be partly explained by reduced plasma fatty acid availability
[19]. However, more complex mechanisms were probably prevail-
ing. In particular, PGC1a is known to enhance PPARa activity in
skeletal muscle [23]. Therefore, a training cessation-induced de-
crease in PGC1a expression is consistent with a reduction in PPARa
activity but forecasts further adaptations in mitochondrial biogen-
esis and respiratory activity through PGC1a-associated changes in
the expression of NRF1-dependent genes [24].
A 3-h insulin clamp was used in order to evidence small
changes in peripheral insulin sensitivity. Before training cessation,
measurements were performed after the subject refrained from
training for 2 days, as it has been shown that the acute effect of
exercise on insulin-stimulated glucose metabolism is rapidly re-
versed [25,26]. In our conditions, the present data did not evidence
changes in peripheral insulin sensitivity after 4 weeks of training
cessation. This would be in agreement with earlier studies in
trained humans and animals [25,26], although some previous
training cessation protocols have highlighted a signiﬁcant decline
in insulin sensitivity over a short period of time (<4 weeks)
[27,28]. This discrepancy may be explained by the fact our volun-
teers were not highly trained (VO2max = 53.2 ± 3.8 ml/min/kg BW)
by contrast to the athletes studied in these latter studies
(VO2max > 60 ml/min/kg BW) [27,28]. Indeed, the magnitude of loss
of exercise-induced metabolic adaptations during training cessa-
tion is suggested to increase with ﬁtness level [29]. Therefore, as
insulin sensitivity was still signiﬁcantly higher in our trained vol-
unteers after training cessation compared to sedentary controls, a
decline in insulin sensitivity would be expected after a longer
period of training cessation.
Recent studies have demonstrated that high-fat diet induced-
insulin resistance can be dissociated from muscle mitochondrial
function [9]. Our present results corroborate this latest evidence,
as impaired OXFA was not directly related to changes in insulin sen-
sitivity, even though the volunteers were gaining weight. There-
fore, in agreement with Holloszy [30], we propose that the two
metabolic pathways may not be tightly linked. Decreased fatty acid
uptake by the muscle cell, as hypothesized above, might be one of
the missing links. This hypothesis would support cellular mecha-
nisms of insulin resistance [6,7] and would agree with the acute
fatty acid-induced-insulin resistance during lipid/heparin clamp-
ing [31]. Our present results would suggest that insulin sensitivity
may be determined (at least in part) by the interaction between
intramyocellular fatty acid trafﬁcking and mitochondrial fatty acid
oxidation rate.
Fig. 2. PGC-1a and PPARa muscle gene expression relative to cyclophilin mRNA before and after 4 weeks of training cessation (A and C, respectively) and relative to pre-
training value (B and D, respectively) (n = 9).
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Fig. 3. Respiratory exchange ratio during moderate aerobic power tests before and
after 4 weeks of training cessation (n = 14). Pre- and post-training cessation tests
were performed at the same relative intensities.  and  = signiﬁcantly different
from pre-training cessation values at P < 0.05 and P < 0.01, respectively. Results are
expressed as means ± S.E.
2932 V. Rimbert et al. / FEBS Letters 583 (2009) 2927–2933In conclusion, short-term training cessation is associated with
fat mass gain, decreased plasma NEFA concentrations, down-regu-
lation of PPARa and PGC1a gene expression and impairment of the
muscle fat oxidative pathway. The decline in the muscle fat oxida-
tive pathway is involved in the regulation of whole body fat bal-
ance during physical exercise. However, it is not directly
associated with the deterioration of insulin sensitivity.
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